CHEMOCENTRYX INC (CCXI) Stock Analyst Earnings Estimates
NASDAQ:CCXI - Nasdaq - US16383L1061 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 36.13M -15.74% | 64.89M 79.60% | 32.224M -50.34% | 73.845M 129.16% | 224.88M 204.53% | 412.667M 83.51% | 987.239M 139.23% | 2.409B 144.02% | |
| EBITDA YoY % growth | -56.66M -42.51% | -54.38M 4.02% | -126.78M -133.14% | -130.458M -2.90% | 18.768M 114.39% | 174.42M 829.35% | 427.5M 145.10% | 1.069B 150.00% | |
| EBIT YoY % growth | -58.3M -44.77% | -55.18M 5.35% | -129.919M -135.45% | -122.735M 5.53% | -15.024M 87.76% | 144.567M 1,062.21% | 354.33M 145.10% | 885.825M 150.00% | |
| Operating Margin | -161.36% | -85.04% | -403.17% | -166.21% | -6.68% | 35.03% | 35.89% | 36.77% | |
| EPS YoY % growth | -0.97 -27.63% | -0.84 13.40% | -1.89 -125.00% | -1.71 9.69% | -0.23 86.75% | 1.52 774.43% | 3.74 145.10% | 9.34 150.00% |
All data in USD
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.39 -20.59% | -0.30 48.71% | -0.21 61.52% | -0.10 77.40% | 0.03 107.27% | 0.14 147.14% |
| Revenue Q2Q % growth | 22.393M 26.21% | 34.297M 1,381.51% | 37.363M 584.42% | 47.792M 306.29% | 58.731M 162.27% | 69.985M 104.06% |
| EBITDA Q2Q % growth | -39.78M -102.13% | -38.76M -5.01% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -28.186M -29.28% | -21.873M 45.39% | -20.868M 45.42% | -12.415M 60.68% | -3.393M 87.96% | 4.959M 122.67% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -0.44 21.43% | -0.50 | 0.06 | 12.63% |
| Q1 2022 Q2Q % growth | -0.55 -27.91% | -0.32 | -0.23 | -73.94% |
| Q4 2021 Q2Q % growth | -0.58 -34.88% | -0.60 | 0.02 | 2.59% |
| Q3 2021 Q2Q % growth | -0.32 8.57% | -0.46 | 0.14 | 29.70% |
| Q2 2021 Q2Q % growth | -0.56 -293.10% | -0.56 | 0.00 | -0.74% |
| Q1 2021 Q2Q % growth | -0.43 -22.86% | -0.41 | -0.02 | -4.09% |
| Q4 2020 Q2Q % growth | -0.43 -65.38% | -0.34 | -0.09 | -26.65% |
| Q3 2020 Q2Q % growth | -0.35 -59.09% | -0.32 | -0.03 | -10.24% |
| Q2 2020 Q2Q % growth | 0.29 211.54% | -0.35 | 0.64 | 183.62% |
| Q1 2020 Q2Q % growth | -0.35 -52.17% | -0.31 | -0.04 | -14.38% |
| Q4 2019 Q2Q % growth | -0.26 | -0.27 | 0.01 | 2.59% |
| Q3 2019 Q2Q % growth | -0.22 | -0.29 | 0.07 | 22.97% |
| Q2 2019 Q2Q % growth | -0.26 | -0.22 | -0.04 | -18.17% |
| Q1 2019 Q2Q % growth | -0.23 | -0.24 | 0.01 | 4.91% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | 11.763M 548.81% | 12.909M | -1.146M | -8.87% |
| Q1 2022 Q2Q % growth | 5.459M -47.26% | 21.797M | -16.338M | -74.96% |
| Q4 2021 Q2Q % growth | 2.315M -46.90% | 4.307M | -1.992M | -46.25% |
| Q3 2021 Q2Q % growth | 17.743M 248.59% | 13.746M | 3.997M | 29.07% |
| Q2 2021 Q2Q % growth | 1.813M -96.33% | 4.944M | -3.131M | -63.33% |
| Q1 2021 Q2Q % growth | 10.35M 72.21% | 8.087M | 2.263M | 27.98% |
| Q4 2020 Q2Q % growth | 4.36M -56.62% | 8.154M | -3.794M | -46.53% |
| Q3 2020 Q2Q % growth | 5.09M -51.89% | 10.915M | -5.825M | -53.37% |
| Q2 2020 Q2Q % growth | 49.44M 589.54% | 8.413M | 41.027M | 487.66% |
| Q1 2020 Q2Q % growth | 6.01M -27.85% | 8.926M | -2.916M | -32.67% |
| Q4 2019 Q2Q % growth | 10.05M | 9.877M | 173.003K | 1.75% |
| Q3 2019 Q2Q % growth | 10.58M | 7.854M | 2.726M | 34.71% |
| Q2 2019 Q2Q % growth | 7.17M | 10.025M | -2.855M | -28.48% |
| Q1 2019 Q2Q % growth | 8.33M | 11.186M | -2.856M | -25.53% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |